Deep Apple is the latest biotech to be tapped by Novo Nordisk as the drugmaker aims to regain market share lost to Eli Lilly.

Lexaria Bioscience (LEXX) announced that human study GLP-1-H25-5 which compared oral capsules of DehydraTECH-liraglutide to ...

For patients with obesity initiating pharmacotherapy with semaglutide or tirzepatide, weight loss at one year is 8.7 percent ...

Experts say that semaglutide and tirzepatide can help patients with heart failure lose weight, but limited NHS access is ...

Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

Weight loss jabs like mounjaro could be as transformative as statins, the NHS’s top doctor has said. Cholesterol-busting ...